Roman Leader
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roman Leader has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Vladimirovich Korotkikh
Amur State Medical Academy of the Ministry of Health of the Russian Federation (Amur SMA)
3 shared publications - Anton Nikolaevich Kazantsev
135th Separate Medical Battalion of the Ministry of Defense of the Russian Federation
3 shared publications - Ludmila V. Roshkovskaya
City Alexander Hospital, St. Petersburg, Russian Federation
2 shared publications - Maxim P. Chernyavin
Hospital for War Veterans № 2, Moscow Healthcare Department; Yaroslavl State Medical University, Ministry of Health of the Russian Federation
2 shared publications - Sergey V. Artyukhov
Alexandrovskaya hospital
2 shared publications - Vladimir M. Unguryan
Kostroma Regional Oncology Dispensary
2 shared publications
Latest Publications
- 19 June 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 40 (6) , 675-683
One year outcomes following of carotid endarterectomy in different age groups: Russian multicenter study
Introduction This is a retrospective analysis of the results of carotid endarterectomy (CEA) in different age groups. Methods This cohort, comparative, retrospective, open-label study for the period from 2008 to 2020 included 7248 patients with hemodynamically significant stenoses of the internal carotid artery (ICA), who underwent CEA. According to the classification of the World Health Organization, patients were divided into groups depending on age: up to 44 years—young age (n = 84); 45–60 years—middle age (n = 1635); 61–75—elderly age (n = 4817); over 75 years—senile age (n = 712). Results In terms of the frequency of hospital complications, the group of patients over 75 years of age experienced the largest number of cardiovascular events. One year after surgery, there were no significant differences in the incidence of complications between groups: death (group 1, 1.2%; group 2, 0.5%; group 3, 0.4%; group 4, 1%; p = 0.14), myocardial infarction (group 1, 1.2%; group 2, 0.3%; group 3, 0.14%; group 4, 0.3%; p = 0.12), stroke (group 1, 0%; group 2, 0.3%; group 3, 0.1%; group 4, 0.4%; p = 0.32). Conclusion The largest number of adverse cardiovascular events after CEA are observed among patients over 75 years of age, which is due to the high frequency of multivessel coronary lesions, atrial fibrillation, and the severity of the comorbidities. One year after surgery, there were no significant differences in the incidence of complications between groups.
- 19 June 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 40 (6) , 675-683
One year outcomes following of carotid endarterectomy in different age groups: Russian multicenter study
Introduction This is a retrospective analysis of the results of carotid endarterectomy (CEA) in different age groups. Methods This cohort, comparative, retrospective, open-label study for the period from 2008 to 2020 included 7248 patients with hemodynamically significant stenoses of the internal carotid artery (ICA), who underwent CEA. According to the classification of the World Health Organization, patients were divided into groups depending on age: up to 44 years—young age (n = 84); 45–60 years—middle age (n = 1635); 61–75—elderly age (n = 4817); over 75 years—senile age (n = 712). Results In terms of the frequency of hospital complications, the group of patients over 75 years of age experienced the largest number of cardiovascular events. One year after surgery, there were no significant differences in the incidence of complications between groups: death (group 1, 1.2%; group 2, 0.5%; group 3, 0.4%; group 4, 1%; p = 0.14), myocardial infarction (group 1, 1.2%; group 2, 0.3%; group 3, 0.14%; group 4, 0.3%; p = 0.12), stroke (group 1, 0%; group 2, 0.3%; group 3, 0.1%; group 4, 0.4%; p = 0.32). Conclusion The largest number of adverse cardiovascular events after CEA are observed among patients over 75 years of age, which is due to the high frequency of multivessel coronary lesions, atrial fibrillation, and the severity of the comorbidities. One year after surgery, there were no significant differences in the incidence of complications between groups.
- 14 June 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 39 (6) , 608-614
Prospective multicenter online testing of the carotid endarterectomy risk stratification calculator carotidscore.ru
Aim To evaluate the incidence of complications, including fatal outcomes, ischemic strokes, and transient ischemic attacks, associated with carotid endarterectomy (CEA) in patients categorized as low-, medium-, and high-risk based on their CarotidSCORE (carotidscore.ru). Material and Methods This prospective, multicenter study was conducted from January 1, 2022, to December 20, 2022, and enrolled 5,496 patients with stenosis of the internal carotid artery (ICA), who were categorized into four groups according to their risk level. Group 1 (n=1,759) included patients at low risk; Group 2 (n=2,483) included those at medium risk; Group 3 (n=429) included those at high risk, who underwent carotid angioplasty with stenting (CAS) due to the high risk of complications associated with carotid endarterectomy (CEA); and Group 4 (n=825) did not use CarotidSCORE (carotidscore.ru). Patients in Groups 1, 2, and 4 underwent CEA. Results During the postoperative hospital stay, the highest number of complications, including fatal outcomes (p=0.0007), ischemic strokes (p<0.0001), and the combined endpoints (p<0.0001) were observed in Group 4. No complications were reported in Group 1. Conclusion The use of CarotidSCORE (carotidscore.ru) allows for the identification of high-risk patients, enabling clinicians to opt for CAS instead of CEA and reduce the incidence of complications.
- 14 June 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 39 (6) , 608-614
Prospective multicenter online testing of the carotid endarterectomy risk stratification calculator carotidscore.ru
Aim To evaluate the incidence of complications, including fatal outcomes, ischemic strokes, and transient ischemic attacks, associated with carotid endarterectomy (CEA) in patients categorized as low-, medium-, and high-risk based on their CarotidSCORE (carotidscore.ru). Material and Methods This prospective, multicenter study was conducted from January 1, 2022, to December 20, 2022, and enrolled 5,496 patients with stenosis of the internal carotid artery (ICA), who were categorized into four groups according to their risk level. Group 1 (n=1,759) included patients at low risk; Group 2 (n=2,483) included those at medium risk; Group 3 (n=429) included those at high risk, who underwent carotid angioplasty with stenting (CAS) due to the high risk of complications associated with carotid endarterectomy (CEA); and Group 4 (n=825) did not use CarotidSCORE (carotidscore.ru). Patients in Groups 1, 2, and 4 underwent CEA. Results During the postoperative hospital stay, the highest number of complications, including fatal outcomes (p=0.0007), ischemic strokes (p<0.0001), and the combined endpoints (p<0.0001) were observed in Group 4. No complications were reported in Group 1. Conclusion The use of CarotidSCORE (carotidscore.ru) allows for the identification of high-risk patients, enabling clinicians to opt for CAS instead of CEA and reduce the incidence of complications.
- Open Access
- 9 August 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (7) , 5091
Thrombosis in unvaccinated and Gam-COVID-Vac-vaccinated patients with COVID-19
Aim. To analyze the incidence of thrombotic events in unvaccinated and GamCOVID-Vac-vaccinated patients with coronavirus disease 2019 (COVID-19).Material and methods. This prospective study included 316 patients (group 1) vaccinated with two doses of Sputnik V (Gam-COVID-Vac) hospitalized between November 20, 2020 and June 1, 2021 for COVID-19. Group 2 included 754 unvaccinated patients with a positive polymerase chain reaction test for SARSCoV-2.Results. During inhospital period, deaths were recorded only in unvaccinated patients (group 1 — 0%; group 2 — 10,7% (n=87); pConclusion. Vaccination with Sputnik V (Gam-COVID-Vak) prevents the severe COVID-19 with the development of deaths, pulmonary embolism, venous and arterial thrombosis.
- 9 August 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (7) , 5091
Open AccessThrombosis in unvaccinated and Gam-COVID-Vac-vaccinated patients with COVID-19
Aim. To analyze the incidence of thrombotic events in unvaccinated and GamCOVID-Vac-vaccinated patients with coronavirus disease 2019 (COVID-19).Material and methods. This prospective study included 316 patients (group 1) vaccinated with two doses of Sputnik V (Gam-COVID-Vac) hospitalized between November 20, 2020 and June 1, 2021 for COVID-19. Group 2 included 754 unvaccinated patients with a positive polymerase chain reaction test for SARSCoV-2.Results. During inhospital period, deaths were recorded only in unvaccinated patients (group 1 — 0%; group 2 — 10,7% (n=87); pConclusion. Vaccination with Sputnik V (Gam-COVID-Vak) prevents the severe COVID-19 with the development of deaths, pulmonary embolism, venous and arterial thrombosis.